Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection

Yellow fever virus (YFV) is a reemerging global health threat, driven by several factors, including increased spread of the mosquito vector and rapid urbanization. Although a prophylactic vaccine exists, vaccine hesitancy, supply deficits, and distribution difficulties leave specific populations at...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricciardi, Michael J., Rust, Lauren N., Pedreño-Lopez, Nuria, Yusova, Sofiya, Biswas, Sreya, Webb, Gabriela M., Gonzalez-Nieto, Lucas, Voigt, Thomas B., Louw, Johan J., Laurino, Fernanda D., DiBello, John R., Raué, Hans-Peter, Barber-Axthelm, Aaron M., Chun, Kimberly, Uttke, Samantha, Raphael, Lidiane M. S., Yrizarry-Medina, Aaron, Rosen, Brandon C., Agnor, Rebecca, Gao, Lina, Labriola, Caralyn, Axthelm, Michael, Smedley, Jeremy, Julander, Justin G., Bonaldo, Myrna C., Walker, Laura M., Messaoudi, Ilhem, Slifka, Mark K., Burton, Dennis R., Kallas, Esper G., Sacha, Jonah B., Watkins, David I., Burwitz, Benjamin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617428/
https://www.ncbi.nlm.nih.gov/pubmed/36989376
http://dx.doi.org/10.1126/scitranslmed.ade5795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617428/
https://www.ncbi.nlm.nih.gov/pubmed/36989376
http://dx.doi.org/10.1126/scitranslmed.ade5795

Ejemplares similares